Trending: Pfizer, BioNTech Seek OK for Covid-19 Booster in Kids
2022年9月26日 - 11:48PM
Dow Jones News
10:18 ET -- Pfizer Inc. and BioNTech SE are two of the most
talked about companies in the U.S. across all news items in the
last 12 hours, according to Factiva data. The vaccine partners have
asked the U.S. Food and Drug Administration to approve the use of
their updated Covid-19 booster, which targets the original strain
and the fast-spreading Omicron variants, in children ages 5 through
11. An FDA decision could come before the end of the year. Dow
Jones & Co. owns Factiva. (colin.kellaher@wsj.com)
(END) Dow Jones Newswires
September 26, 2022 10:33 ET (14:33 GMT)
Copyright (c) 2022 Dow Jones & Company, Inc.
Pfizer (NYSE:PFE)
過去 株価チャート
から 3 2024 まで 4 2024
Pfizer (NYSE:PFE)
過去 株価チャート
から 4 2023 まで 4 2024